I have been following this stock for a while, and there is absolutely no substance for existing inflated stock price.
The stock jumped from .10 to .16 (60%) in 2 days based on a product shipment announcement. Very weak information about the product line and quantity of shipment is available. Just that a shipment happened.
This company supposedly released seven products in less than two and a half years but during that time the stock price remained .7 .8
This company is in very bad financial shape
They have zero revenue, less than $4.8 million in cash – almost $500k in liabilities and an increased net loss of $2.4 million last quarter
The financials are the only facts we have at this stage, and they are alarming
We have very little available information or certain facts out there to back the company, technology and products, only that they have generic prescriptions.
There is absolutely no true analysis to quantify the massive spike that we have seen, this stock is completely oversold.
The stock price is going to come down fast until the basic fundamentals of this company can be backed up by any reputational source and it can be trusted.
There is a reason why they are still a minute penny stock.
This is the same game being played over and over again. Look at previous spikes caused by prior articles, they came down pretty quickly since they have no substance.
There are certain investors that benefit from these hypes. Their timing and press releases are immaculate, and they will leave you hanging.
There are always a new stories to tell to create excitement.
Whichever way you look this price surge is based on limited and unverified information.
I know we all want stock to work in our favor, but sometimes the right decision is to walk away.
Look at the history and decide for yourself.
StockBastid Elite is in bad financial shape? How's that?
FACT They are in the best financial shape in the long history of the company.
With the launch of Naltrexone and shipment of product they are making substantial progress
on BUILDING revenues. Close to CFP.
Lincoln Park Capital Finance will provide them with UP to 10 million should they need it.
They are $4 million in debt. Not much.
Partner to be announced for the ANDAs along with Human Clinical BE studies to start in about a month or so
for their ABUSE RESISTANT TECHNOLOGY oxycodone once a days and twice a days. Data to be completed about June time frame 2014. The FDA loves this pharcological approach and MAY end up EMBRACING it as the SRT by which all others are measured.
Micro pill patent to get approval SOON. Not only good for ALL medications, but also good for ELI-216. Add more years to the 20 year patents ELI-216 already has. ELI-216 good for ALL OPIOIDS! Plug and play.
EII-154 may enter the patent mix yet again. Extended release for all opioids.
Yeah this company is in "bad" shape. LMAO~! NOT HARDLY~!
You sausage swallowing bashturds RELLY getting desperate. WOW~!
Sentiment: Strong Buy
they make people like you believe - and then leave you with an empty bag - I wish that it was not the case but it happens over and over again - all the newbies are left stranded - look at the graph